Magadh Sugar & Energy Limited (MAGADSUGAR.NS)
INR 683.2
(-0.21%)
INR 683.2
(-0.21%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.38 Million | 1.14 Billion | 1.46 Billion | 1.25 Billion | -165.33 Million | 405.34 Million |
| Net Income | 1.16 Billion | 770.9 Million | 664.49 Million | 423.11 Million | 1.07 Billion | 538.68 Million |
| Depreciation & Amortization | 254.25 Million | 252.87 Million | 210.06 Million | 192.76 Million | 181.08 Million | 181.43 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.45 Billion | -30.61 Million | 309.55 Million | 177.75 Million | -1.73 Billion | -580.62 Million |
| Other non-cash items | 1.93 Billion | 154.72 Million | 283.45 Million | 458 Million | 309.94 Million | 265.85 Million |
| Investing Cash Flow | -433.55 Million | -208.63 Million | -1.05 Billion | -524.34 Million | -360.74 Million | -238.81 Million |
| Investments in PPE | -476.39 Million | -218.28 Million | -1.06 Billion | -534.89 Million | -364.94 Million | -273.62 Million |
| Acquisitions | 486 Thousand | 377 Thousand | 1.44 Million | 2.65 Million | 1.25 Million | 29.91 Million |
| Investment purchases | -5.6 Million | -377 Thousand | - | - | - | -200 Thousand |
| Sales/Maturities of investments | - | 200 Thousand | - | - | - | -29.71 Million |
| Other Investing Activities | 47.96 Million | 9.45 Million | 6.55 Million | 7.89 Million | 2.94 Million | 34.8 Million |
| Financing Cash Flow | 439.2 Million | -940.23 Million | -411.58 Million | -729.37 Million | 527.64 Million | -168.92 Million |
| Debt repayment | -709.34 Million | -1.03 Billion | -375 Million | -310.46 Million | -440.32 Million | -595.41 Million |
| Dividends payments | -98.64 Million | -91.59 Million | -56.36 Million | -56.36 Million | -24.26 Million | -12.13 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -170 Million | 190.03 Million | 19.77 Million | -362.54 Million | 992.22 Million | 438.62 Million |
| Accounts receivables | -6.33 Million | 142.75 Million | -339.62 Million | -40.97 Million | 115.55 Million | -85.72 Million |
| Accounts payables | 458.59 Million | 673.81 Million | -1.25 Billion | -1.47 Billion | -343.62 Million | 1.78 Billion |
| Inventory | -1.84 Billion | -937.66 Million | 1.86 Billion | 1.12 Billion | -1.18 Billion | -1.96 Billion |
| Other working capital | -56.16 Million | 90.47 Million | 40.79 Million | 574.84 Million | -314.88 Million | -308.71 Million |
| Cash at beginning of period | 4.2 Million | 2.27 Million | 4.22 Million | 6.67 Million | 5.11 Million | 7.51 Million |
| Cash at end of period | 10.7 Million | 1.3 Million | 2.27 Million | 4.58 Million | 6.67 Million | 5.11 Million |
| Capital Expenditure | -476.39 Million | -218.28 Million | -1.06 Billion | -534.89 Million | -364.94 Million | -273.62 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 6.49 Million | -975 Thousand | -1.94 Million | -2.09 Million | 1.56 Million | -2.39 Million |
| Free Cash Flow | -481.78 Million | 929.6 Million | 401.63 Million | 716.73 Million | -530.27 Million | 131.72 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 114.25 Million | 1.16 Billion | 468.79 Million | 389.08 Million | 150.81 Million | 155.39 Million |
| Depreciation & Amortization | - | 254.25 Million | - | 63.56 Million | 63.32 Million | 62.99 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -1.45 Billion | - | - | - | - |
| Other non-cash items | -114.25 Million | 1.93 Billion | -468.79 Million | -389.08 Million | -150.81 Million | -155.39 Million |
| Investing Cash Flow | - | -433.55 Million | - | - | - | - |
| Investments in PPE | - | -476.39 Million | - | - | - | - |
| Acquisitions | - | 486 Thousand | - | - | - | - |
| Investment purchases | - | -5.6 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 47.96 Million | - | - | - | - |
| Financing Cash Flow | - | 439.2 Million | - | - | - | - |
| Debt repayment | - | -709.34 Million | - | - | - | - |
| Dividends payments | - | -98.64 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -170 Million | - | - | - | - |
| Accounts receivables | - | -6.33 Million | - | - | - | - |
| Accounts payables | - | 458.59 Million | - | - | - | - |
| Inventory | - | -1.84 Billion | - | - | - | - |
| Other working capital | - | -56.16 Million | - | - | - | - |
| Cash at beginning of period | - | 4.2 Million | - | 10.1 Million | -116.55 Million | 4.2 Million |
| Cash at end of period | - | 10.7 Million | - | 137.22 Million | 10.1 Million | 130.19 Million |
| Capital Expenditure | - | -476.39 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 6.49 Million | - | 127.12 Million | 126.65 Million | 125.99 Million |
| Free Cash Flow | - | -481.78 Million | - | 127.12 Million | 126.65 Million | 125.99 Million |
EXCELINDUS
AARTIPHARM
ALB
DKM
4265
TPSRF